Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Anglogold Ashanti | AU | Nov 22, 2024 | 25.95 | +2.98 |
Anheuser-Busch InBev ADR | BUD | Nov 22, 2024 | 54.73 | +0.07 |
ANI Pharmaceuticals | ANIP | Nov 22, 2024 | 56.91 | +1.88 |
Anika Therapeutics | ANIK | Nov 22, 2024 | 16.97 | -2.64 |
Anixa Biosciences | ANIX | Nov 22, 2024 | 3.20 | +4.58 |
Annaly Capital Management | NLY | Nov 22, 2024 | 19.81 | +0.15 |
Annaly Capital Management F Pref | NLY-F | Nov 22, 2024 | 25.80 | -0.50 |
Annaly Capital Management G Pref | NLY-G | Nov 22, 2024 | 25.53 | -0.04 |
Annaly Capital Management I Pref | NLY-I | Nov 22, 2024 | 25.80 | -0.21 |
Annexon | ANNX | Nov 22, 2024 | 5.14 | -0.58 |
Annovis Bio | ANVS | Nov 22, 2024 | 6.65 | -2.06 |
ANSYS | ANSS | Nov 22, 2024 | 350.00 | +0.30 |
Antelope Enterprise | AEHL | Nov 22, 2024 | 0.26 | +0.91 |
Anterix | ATEX | Nov 22, 2024 | 33.72 | +1.47 |
Antero Midstream | AM | Nov 22, 2024 | 15.77 | -0.06 |
Antero Resources | AR | Nov 22, 2024 | 33.11 | -0.87 |
Anywhere Real Estate | HOUS | Nov 22, 2024 | 4.59 | +5.28 |
Aon | AON | Nov 22, 2024 | 386.21 | +0.94 |
APA | APA | Nov 22, 2024 | 22.77 | +1.47 |
Apartment Investment and Management | AIV | Nov 22, 2024 | 8.84 | +0.68 |
Apellis Pharmaceuticals | APLS | Nov 22, 2024 | 30.77 | +10.88 |
APi Group | APG | Nov 22, 2024 | 37.01 | +0.03 |
Apogee Enterprises | APOG | Nov 22, 2024 | 83.22 | +1.35 |
Apogee Therapeutics | APGE | Nov 22, 2024 | 43.46 | +1.40 |
Apollo Commercial Real Estate Finance | ARI | Nov 22, 2024 | 9.19 | -0.11 |
Apollo Global Management | APO | Nov 22, 2024 | 167.56 | +1.54 |
Apollomics A | APLM | Nov 22, 2024 | 0.09 | -9.11 |
AppFolio A | APPF | Nov 22, 2024 | 242.39 | +2.39 |
Appian A | APPN | Nov 22, 2024 | 38.56 | +0.03 |
Apple | AAPL | Nov 22, 2024 | 229.87 | +0.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.